Mineralys Therapeutics Inc.
MLYS | NASDAQ
$28.31
+$0.29 (+1.03%)
At close: Sep 21, 2026, 4:00 PM ET
$28.74
+$0.43 (+1.52%)
Pre-market:
Sep 22, 2026, 7:21 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -15.85 | -3.36 | -4.32 | -3.20 | -4.74 | -24.92 |
PEG Ratio | 0.42 | -0.04 | 0.07 | -0.07 | -0.01 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.80 | 3.12 | 1.29 | -1.82 | -4.01 | -23.74 |
P/FCF Ratio | -17.24 | -3.59 | -3.83 | -3.26 | -6.31 | -34.66 |
P/OCF Ratio | -17.24 | -3.59 | -3.83 | -3.26 | -6.31 | -34.66 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | -1.25 |
Quick Ratio | 43.76 | 14.02 | 23.76 | 13.98 | 2.20 | 0.29 |
Current Ratio | 43.76 | 14.02 | 23.76 | 13.98 | 2.20 | 0.29 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -18.78 | -693.52 | -25.59 |
Return on Equity | -23.91% | -92.97% | -29.81% | 57.01% | 84.66% | 95.25% |
Return on Assets | -23.37% | -86.36% | -28.57% | -26.04% | -174.45% | -230.55% |
Return on Invested Capital | -26.38% | -100.60% | -35.10% | -29.59% | -308.43% | -325.91% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MLYS